KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifeward (LFWD) Research & Development (2016 - 2025)

Lifeward's Research & Development history spans 11 years, with the latest figure at $721000.0 for Q3 2025.

  • For Q3 2025, Research & Development fell 27.76% year-over-year to $721000.0; the TTM value through Sep 2025 reached $3.5 million, down 26.5%, while the annual FY2024 figure was $4.6 million, 11.5% up from the prior year.
  • Research & Development for Q3 2025 was $721000.0 at Lifeward, down from $767000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $1.3 million in Q4 2023 and bottomed at $638000.0 in Q3 2021.
  • The 5-year median for Research & Development is $918000.0 (2025), against an average of $955210.5.
  • The largest annual shift saw Research & Development surged 71.68% in 2024 before it plummeted 36.35% in 2025.
  • A 5-year view of Research & Development shows it stood at $696000.0 in 2021, then soared by 58.48% to $1.1 million in 2022, then increased by 19.49% to $1.3 million in 2023, then decreased by 14.19% to $1.1 million in 2024, then plummeted by 36.25% to $721000.0 in 2025.
  • Per Business Quant, the three most recent readings for LFWD's Research & Development are $721000.0 (Q3 2025), $767000.0 (Q2 2025), and $918000.0 (Q1 2025).